Alumis (ALMS) Shares Repurchased (2023)
Alumis (ALMS) reported Shares Repurchased of $13000.0 for Q3 2023.
Alumis (ALMS) has 1 years of Shares Repurchased data on file, last reported at $13000.0 in Q3 2023.
- Quarterly Shares Repurchased changed N/A year-over-year to $13000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2025 was $13000.0 (changed N/A YoY) and the FY2025 annual result came in at $17000.0, up 183.33% from the prior year.
- Shares Repurchased was little changed at $13000.0 in Q3 2023 per ALMS's latest filing.
- Across five years, Shares Repurchased topped out at $13000.0 in Q3 2023 and bottomed at $13000.0 in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 336.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 794.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Alumis | 1.84 Bn | 1.75 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 13,000.00 |
| Sep 30, 2023 | 13,000.00 |